Abbott Laboratories (ABT) Competitors & Peers
The 5 companies closest to Abbott Laboratories on the factors that matter — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| SYK | Competitor | $347.18 | P/E 35.9RSI 59Cap 133.1 B |
| MDT | Competitor | $89.91 | P/E 24.1RSI 69Cap 114.9 B |
| BSX | Competitor | $50.91 | P/E 20.7RSI 70Cap 74.1 B |
| EW | Competitor | $93.17 | P/E 55.5RSI 67Cap 53.7 B |
| GEHC | Peer | $72.36 | P/E 16.8RSI 67Cap 33.1 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- PODDPartner
Abbott's FreeStyle Libre 2 Plus sensor integrates with Insulet's Omnipod 5 automated insulin delivery system.
Confirmed — SEC filing / public disclosuresec.gov ↗ - SRDXSupplier
Abbott is Surmodics' exclusive distribution partner for the SurVeil drug-coated balloon (DCB), driving product revenue and paying milestones/licensing fees.
Confirmed — SEC filing / public disclosuresec.gov ↗ - TNDMPartner
Abbott's FreeStyle Libre 2 Plus and 3 Plus continuous glucose monitors integrate directly with Tandem's t:slim X2 and Mobi automated insulin delivery systems.
Confirmed — SEC filing / public disclosuresec.gov ↗ - QTRXLicensor
Quanterix licensed its bead-based single molecule detection patents to Abbott Laboratories for use in in vitro diagnostics (IVD).
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- DXCMCompetitor
Abbott and Dexcom compete directly in the continuous glucose monitoring (CGM) market, with Abbott's FreeStyle Libre competing with Dexcom's G6, G7, and Stelo systems.
Model-inferred, unverified — treat as a lead, not evidence - MCKSupplier
McKesson is a primary healthcare distributor of Abbott's diagnostics, medical devices, and nutritional products to healthcare providers.
Model-inferred, unverified — treat as a lead, not evidence - CAHSupplier
Cardinal Health serves as a key downstream distributor of Abbott's diagnostics and healthcare supplies.
Model-inferred, unverified — treat as a lead, not evidence - CORSupplier
Cencora (formerly AmerisourceBergen) distributes Abbott's pharmaceuticals and nutritional lines to hospitals and specialty pharmacies.
Model-inferred, unverified — treat as a lead, not evidence - CVSCustomer
CVS Health is a major retail pharmacy customer distributing Abbott's OTC nutritional products (Similac) and diagnostics directly to consumers.
Model-inferred, unverified — treat as a lead, not evidence - WBACustomer
Walgreens Boots Alliance distributes Abbott's nutritionals, diagnostics, and pharmaceuticals at retail locations.
Model-inferred, unverified — treat as a lead, not evidence - MDTCompetitor
Medtronic is a primary competitor of Abbott in the medical devices segment, specifically cardiac rhythm management, structural heart, and vascular systems.
Model-inferred, unverified — treat as a lead, not evidence - DXCMCompetitor
DexCom is Abbott's primary competitor in continuous glucose monitoring (CGM) technologies (Dexcom G-series vs Abbott FreeStyle Libre).
Model-inferred, unverified — treat as a lead, not evidence - MDTCompetitor
Abbott competes with Medtronic in the structural heart, cardiac rhythm management, and diabetes segments.
Model-inferred, unverified — treat as a lead, not evidence - EWCompetitor
Abbott competes with Edwards in transcatheter mitral and tricuspid valve repair systems (Abbott MitraClip vs Edwards Pascal).
Model-inferred, unverified — treat as a lead, not evidence - TNDMSupplier
Abbott's continuous glucose monitors (FreeStyle Libre 2 Plus and FreeStyle Libre 3 Plus) are integrated directly with Tandem's t:slim X2 automated insulin delivery systems.
Model-inferred, unverified — treat as a lead, not evidence - PODDSupplier
Abbott's FreeStyle Libre continuous glucose monitoring (CGM) sensors integrate with Insulet's Omnipod 5 automated insulin delivery system.
Model-inferred, unverified — treat as a lead, not evidence - BSXCompetitor
Boston Scientific competes with Abbott in cardiac rhythm management, electrophysiology, and structural heart (e.g., WATCHMAN vs Amulet).
Model-inferred, unverified — treat as a lead, not evidence - SYKCompetitor
Abbott competes with Stryker in cardiac rhythm management, neurovascular, and structural heart devices.
Model-inferred, unverified — treat as a lead, not evidence - SBS.DESupplier
STRATEC develops automated analyzers for Abbott diagnostics.
Model-inferred, unverified — treat as a lead, not evidence - ABBVManufacturer
Following the spinoff of AbbVie in 2013, Abbott Laboratories entered into multi-year transition manufacturing and supply agreements to produce pharmaceutical products for AbbVie.
Model-inferred, unverified — treat as a lead, not evidence - SBS.DEManufacturer
STRATEC develops automated analyzer systems for Abbott's diagnostics division under long-term OEM partnership agreements.
Model-inferred, unverified — treat as a lead, not evidence